Researchers from academia, government, and industry examine current challenges surrounding mass spectrometry as a drug development tool, including its status of adoption by industry and potential regulatory implications.

Forum provides opportunity to share current research and network with potential collaborators.

Representatives meet with faculty and students to learn more about the School’s top ranked academic programs and opportunities for future education and research collaborations.

New collaboration will strengthen SOP’s existing relationship with biopharmaceutical powerhouse and drive novel bioscience research across the State of Maryland and beyond.

Researchers from academia, government, and industry discuss how increasingly large, complex datasets can be harnessed to improve the drug development process.

M-CERSI’s “America’s Got Regulatory Science Talent” judges award student first prize for new technology to combat worldwide counterfeit drug crisis.

New part-time, online graduate program designed for working professionals focuses on drug product development and regulation.

Bruce Yu, PhD, to lead investigation of novel, inexpensive method to detect protein aggregation in biopharmaceutical drugs.

Faculty, staff, and students gather for reception to honor Dr. Myron Weiner’s 36 years of committed teaching, scholarship, and service to the School.